Today, the Honourable Karina Gould, Minister of Democratic Institutions and Member of Parliament for Burlington, announced a FedDev Ontario contribution of over $2.1 million for Harmonic Medical Inc. to accelerate commercialization of its innovative, non-invasive ultrasound therapy equipment used to treat uterine fibroids.

“Supporting Canada’s health and biosciences sector is critical to both the economic success of our economy, and to solving health challenges facing us today. The Government of Canada is proud to support Harmonic Medical Inc. with the development and commercialization of an innovative healthcare technology that has the potential to significantly improve health outcomes for women.”
- The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, Minister responsible for the Federal Economic Development Agency for Southern Ontario

“The Government of Canada is pleased to support a solution that will positively impact women’s health, while creating quality jobs for this region. This support from FedDev Ontario is reflective of the Government’s commitment to growing Canada’s life sciences sector and supporting the adoption of new, innovative technologies to improve quality of life for Canadians.”
- The Honourable Karina Gould, Minister of Democratic Institutions and Member of Parliament for Burlington

“Harmonic Medical’s vision is to redefine surgery – making treatments truly non-invasive. We are poised to bring to market the world’s most advanced therapeutic ultrasound platform that will enable novel treatments for a wide range of diseases from women’s health to cancer. We are grateful for the support from FedDev Ontario. Their contributions will accelerate commercialization of this technology, grow our operations in Canada, and help establish Harmonic Medical as a global leader in focused ultrasound.”
- James O’Reilly, CEO, Harmonic Medical Inc.

• Established in 2010, Harmonic Medical Inc. aims to advance the field of non-invasive surgery with its focused ultrasound device. The company’s platform technology is currently in clinical trials for its initial application—the ablation of uterine fibroids, and carries the future potential to treat a broad range of oncological and non-oncological applications.

• By incorporating numerous proprietary innovations, Harmonic Medical Inc.’s treatment for uterine fibroids offers an incisionless, lower-risk alternative to traditional surgeries, and is designed to be performed by the treating physician.

• Harmonic Medical Inc. has an ongoing research and collaboration partnership with Sunnybrook Research Institute and Health Sciences Centre (Sunnybrook), where its current clinical trial is being held. Sunnybrook is one of seven designated Centres of Excellence in Focused Ultrasound Clinical Research worldwide.

• Since 2012, FedDev Ontario provided nearly $27 million to Sunnybrook to support the development and commercialization of image-guided therapy systems. Harmonic Medical Inc. was supported in the early-stage development of its focused ultrasound technology.

• In addition to the FedDev Ontario repayable contribution, the project will leverage over $5.5 million in private investment.

• This year marks 10 years of FedDev Ontario delivering funding and business services to support innovation and growth in southern Ontario.

Associated links

• FedDev Ontario
• Harmonic Medical Inc.

Media Relations
FedDev Ontario
416-954-6652
fdo.mediarel-relmedias.fdo@canada.ca

Toll Free: 1-866-593-5505
Website: www.FedDevOntario.gc.ca

Stay connected

Subscribe to our news updates and follow us on Twitter @FedDevOntario